Uncommon localization of amyloidosis in gallbladder: Description of a case and brief literature review
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 2
Abstract
Amyloidosis is a rare disease that is caused by extracellular deposits of amorphous, insoluble fibrillar protein, which often occur in the kidneys, the heart, the nervous system, the digestive tract, especially the hepatosplenic and intestinal tract, and can be present in bone marrow, though unusual in the gallbladder. The interest of this case lies in the rarity of amyloidosis localisation and in the uncommon clinical presentation as acute cholecystitis. We have reviewed cases of amyloidosis with gallbladder involvement in literature and briefly discussed thepredictive value of the main histological diagnostic methods.
Authors and Affiliations
Daniela Tirotta, Vittorio Durante
Keywords
Related Articles
- EP ID EP78031
- DOI -
- Views 131
- Downloads 0
Hepatitis C and Its Metabolic Complications in Kidney Disease
Introduction. Evidence has been accumulated during the last decade showing that HCV infection plays an important activity at hepatic and extra-hepatic level. Chronic HCV is associated with a large spectrum of extra-hepat...
Right hepatic lobe resection and thrombocytopenia
Thrombocytopenia has previously been reported after right lobe resection for organ donation. The mechanism(s) of low platelets after right hepatectomy is unclear and several hypotheses have been proposed including a dec...
Giant hepatocellular adenoma in a previously obese thirteen-year-old boy
Hepatocellular adenoma is an uncommon neoplasm, especially in the childhood age group. We describe a previously obese 13-year-old male with a giant hepatocellular adenoma requiring an extensive hepatic resection. The rel...
Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside
Oxidative stress is importantly involved in the pathophysiology of various liver diseases. The redox state participates on the courseof the inflammatory, metabolic and proliferative liver diseases. The main sources of t...
Joint Society statement for elimination of viral hepatitis